Roche’s cobas SARS-CoV-2 Test to detect novel coronavirus receives FDA Emergency Use Authorization and is available in markets accepting the CE mark

Ads

You May Also Like

Cara Therapeutics Appoints Christopher A. Posner to Board of Directors

STAMFORD, Conn., Aug. 06, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical ...

Healthy Stomach Day – aroused wide interest and increased awareness on stomach health

Press release 5th of October 2018 at 12.10 PM local time    International Healthy Stomach Initiative ...